Compare Novartis AG (NVS) vs Wells Fargo & Co (WFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Wells Fargo & Co — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Wells Fargo & Co trades at $87.9 (market cap $261.45B). The key difference: Novartis AG and Wells Fargo & Co are close in size by market cap, and Novartis AG pays the higher dividend (3.17%). Which is the better fit depends on your goals.
| NVS | WFC | |
|---|---|---|
Market Cap | $290.25B | $261.45B |
Sector | Health | Financials |
52-Week High | $168.62 | $96.40 |
52-Week Low | $113.50 | $73.42 |
Enterprise Value | $330.27B | — |
Dividend Yield | 3.17% | 2.09% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Wells Fargo & Co
Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets. The company is split into four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the U.S.
Read more on WFC →
